Orthopedic imaging technology developer EOS Imaging reported a net loss in its 2019 fiscal year as a result of a decrease in equipment orders.
For the year (end-December 31, 2019), the company's total revenue was 21 million euros ($23.9 million U.S.), down from 35.4 million euros ($39.5 million) in 2018. EOS booked 56 equipment orders for the year, compared with 64 orders in 2018.
The decrease in orders was most notable in the U.S., with customers indicating a preference to wait for the upcoming release of the EOSedge orthopedic digital radiography system in the country, the company said. EOS released its EOSedge in Europe and Canada at the end of 2019.
Despite the decrease in orders, comparable commercial performance was slightly higher in 2019 at 35.7 million euros ($39.8 million), compared with 35.4 million euros ($39.5 million) in 2018.
![Representative example of a 16-year-old male patient with underlying X-linked adrenoleukodystrophy. (A, B) Paired anteroposterior (AP) chest radiograph and dual-energy x-ray absorptiometry (DXA) report shows lumbar spine (L1 through L4) areal bone mineral density (BMD). The DXA report was reformatted for anonymization and improved readability. The patient had low BMD (Z score ≤ −2.0). (C) Model (chest radiography [CXR]–BMD) output shows the predicted raw BMD and Z score in comparison with the DXA reference standard, together with interpretability analyses using Shapley additive explanations (SHAP) and gradient-weighted class activation maps. The patient was classified as having low BMD, consistent with the reference standard. AM = age-matched, DEXA = dual-energy x-ray absorptiometry, RM2 = room 2, SNUH = Seoul National University Hospital, YA = young adult.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/ai-children-bone-density.0snnf2EJjr.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
